
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 7.470 | 7.470 | 0.000 |
Shares | 93.450 | 93.450 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.478 | 19.008 |
Price to Book | 3.493 | 2.547 |
Price to Sales | 3.558 | 2.004 |
Price to Cash Flow | 14.515 | 12.000 |
Dividend Yield | 2.051 | 2.319 |
5 Years Earnings Growth | 9.209 | 13.122 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 89.680 | 8.215 |
Industrials | 5.440 | 22.847 |
Consumer Defensive | 4.880 | 9.153 |
Number of long holdings: 25
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Zhejiang Jolly Pharma | CNE100001096 | 7.93 | 19.06 | -0.47% | |
Hunan Fangsheng Pharm | CNE100001VG6 | 7.83 | 11.62 | -1.02% | |
Mabwell Shanghai Bioscience | CNE100005RD2 | 6.98 | 48.00 | +4.58% | |
Ningbo Sanxing Medical Electric | CNE100001567 | 5.08 | 23.03 | +1.19% | |
Xiamen Amoytop Biotech Co | CNE100003RT3 | 4.78 | 83.08 | +0.42% | |
Beijing New Oriental Star Petro Eng | CNE100001X92 | 4.65 | 24.05 | +1.69% | |
InventisBio | CNE100005Q22 | 4.60 | 38.50 | +1.99% | |
Humanwell Healthcare | CNE000000QW6 | 4.57 | 20.40 | -0.63% | |
Runben Biotechnology | CNE100006DK5 | 4.56 | 29.70 | -1.92% | |
Shanghai Allist Pharmaceuticals Co | CNE100005XJ7 | 4.50 | 114.00 | +0.60% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Lord Value Advantage Stock Fund | 1.83B | 10.58 | -11.30 | 7.63 | ||
LACAM China Cyclical Strategy Equit | 606.05M | 14.12 | -9.07 | 9.26 | ||
Lord Growth Advantage Stock Fund | 125.96M | 8.84 | -5.74 | 5.94 | ||
Lord Theme Dynamic Asset Allocation | 9.72M | 5.29 | -5.93 | 2.44 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review